Casa di Cura IGEA
5
4
4
0
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Exercises for Rehabilitation of COgnition and Lifestyle Enhancement in Patients With Mild Cognitive Impairment
Role: lead
Validation of α-synuclein Modifications in Parkinson's dIsoRder Evolution
Role: lead
Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Role: collaborator
Clinical Impact Through AI-assisted MS Care - A Prospective Multi-center Study
Role: collaborator
Italian Adaptation and Validation of Functional and Behavioural Scales for Subjective Cognitive Decline, Mild Cognitive Impairment and Mild Dementia.
Role: lead
All 5 trials loaded